{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-10-09",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "product_ndc": "44567-641",
      "generic_name": "NOREPINEPHRINE BITARTRATE",
      "labeler_name": "WG Critical Care, LLC",
      "brand_name": "NOREPINEPHRINE BITARTRATE IN SODIUM CHLORIDE",
      "active_ingredients": [
        {
          "name": "NOREPINEPHRINE BITARTRATE",
          "strength": ".032 mg/mL"
        }
      ],
      "finished": true,
      "packaging": [
        {
          "package_ndc": "44567-641-10",
          "description": "10 BAG in 1 CARTON (44567-641-10)  / 250 mL in 1 BAG (44567-641-01)",
          "marketing_start_date": "20221031",
          "sample": false
        }
      ],
      "listing_expiration_date": "20271231",
      "openfda": {},
      "marketing_category": "NDA",
      "dosage_form": "INJECTION, SOLUTION",
      "spl_id": "2c00d1f5-dc7f-48a6-8347-5114a389b662",
      "product_type": "HUMAN PRESCRIPTION DRUG",
      "route": [
        "INTRAVENOUS"
      ],
      "marketing_start_date": "20220915",
      "product_id": "44567-641_2c00d1f5-dc7f-48a6-8347-5114a389b662",
      "application_number": "NDA215700",
      "brand_name_base": "NOREPINEPHRINE BITARTRATE IN SODIUM CHLORIDE",
      "pharm_class": [
        "Catecholamine [EPC]",
        "Catecholamines [CS]"
      ]
    }
  ]
}